Freddy Galvis gets 50-game PED suspension

36 Comments

Apparently, he’s the new Manny Alexander.

Injured Phillies infielder Freddy Galvis was suspended 50 games Tuesday after testing positive for Clostebol, a performance-enhancing substance.

In a statement, Galvis claimed that “a trace amount of a banned substances — 80 parts in a trillion — was detected in my urine sample” and that he’d never knowingly take a banned substance. He apologized to “all of my fans, especially here in Philadelphia and back home in Venezuela, to my teammates and to the Phillies organization.”

Taking over as the Phillies’ starting second baseman with Chase Utley out, Galvis was hitting .226/.254/.363 with three homers and 24 RBI in 190 at-bats when he suffered a back injury earlier this month. The injury was later diagnosed as a fractured vertebra and was expected to sideline Galvis for at least another month, if not for most of the rest of the season.

Galvis will be able to serve his suspension while on the disabled list, so it might not actually cost him any additional time. It will cost him about $150,000 in salary, though.

While Galvis’ offensive production was modest, it was still a somewhat pleasant surprise given his history. He had 19 extra-base hits in 190 at-bats for the Phillies, an average of one every 10 at-bats. In his four minor league seasons, he averaged one extra-base hit every 19.6 at-bats. His 15 doubles led the Phillies at the time of his injury.

Update: The Phillies have released a statement:

The Phillies continue to believe in and endorse Major League Baseball’s drug policy. We also support Freddy Galvis in his determination to put this matter behind him and we look forward to his return as a productive member of the Phillies as soon as possible.

After the suspension was announced, Galvis tweeted, in Spanish, about turning the page:

White Sox sign Ervin Santana to minors deal

Ervin Santana
Getty Images
Leave a comment

Free agent right-hander Ervin Santana picked up a minor league deal with the White Sox, according to various reports Friday. Per Bruce Levine of 670thescore.com, Santana will make $4.33 million if he manages to crack the major-league roster this spring. Any official confirmation from the team is still dependent on the results of a physical.

The veteran righty hasn’t seen any action in MLB for some time. He was laid low by prolonged discomfort in his right middle finger last spring, and underwent a capsular release/debridement procedure that kept him off the mound for all but 24 2/3 innings of his 2018 campaign with the Twins. When healthy, however, he’s been as durable and productive as they come. Santana earned his second career All-Star distinction in 2017 and pitched to a 16-8 record in 33 starts with three shutouts, a 3.28 ERA, 2.6 BB/9, 7.1 SO/9, and 2.9 fWAR through 211 1/3 innings.

Barring further complications with his pitching hand, the 36-year-old should be a stabilizing force for the White Sox’ rotation in 2019 — assuming he can beat out southpaw Manny Bañuelos and right-handers Jordan Stephens and Dylan Covey for a back-end role, that is. According to FanGraphs, the club’s starters ranked worst in the league in 2018 with a collective 5.07 ERA, 5.18 FIP, and 3.1 fWAR.